Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON) will present a fireside chat at the Piper Sandler 37th Annual Healthcare Conference in New York City on Thursday, December 4, 2025 at 9:30 AM ET.

Members of the company's executive leadership team will host the session at the Lotte New York Palace. Investors seeking a one-on-one meeting should contact their Piper Sandler institutional sales representative to schedule engagements.

News Market Reaction – ETON

+2.71%

3 alerts

+2.71% Session close to close

$420.77M Market Cap

0.6x Rel. Volume

In the Nov 25 session, ETON gained 2.71%, reflecting a moderate positive market reaction. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DEER PARK, Ill., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team, will host a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in NYC as follows:

DATE: Thursday, December 4, 2025
TIME: 9:30AM ET
LOCATION: Lotte New York Palace

To schedule a 1x1 meeting with the Company, please contact your Piper Sandler institutional sales representative.

About Eton Pharmaceuticals
Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX^®, ALKINDI SPRINKLE^®, GALZIN^®, PKU GOLIKE^®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ET-600, Amglidia^®, ET-700, ET-800 and ZENEO^® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals.

FAQ

When will Eton Pharmaceuticals (ETON) present at the Piper Sandler conference?

Eton will present a fireside chat on December 4, 2025 at 9:30 AM ET.

Where is Eton's presentation located for the Piper Sandler 37th Annual Healthcare Conference?

The presentation is at the Lotte New York Palace in New York City.

Who from Eton Pharmaceuticals will appear at the Piper Sandler conference?

Members of Eton's executive leadership team will host the fireside chat.

How can investors schedule a one-on-one meeting with Eton (ETON) at the conference?

To schedule a 1x1 meeting, contact your Piper Sandler institutional sales representative.

Is the Eton (ETON) session at Piper Sandler a fireside chat or a formal presentation?

Eton's session is billed as a fireside chat with executive leadership.

What is the date and time for Eton Pharmaceuticals' event at the Piper Sandler conference?

The event is scheduled for Thursday, December 4, 2025 at 9:30 AM ET.